Concentric Analgesics
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
101 California St Ste 1210, San Francisc...Phone Number
(415) 484-7921Website
www.concentricanalgesics.comRevenue
$8.4 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Concentric Analgesics
Concentric Analgesics is a biotechnology company that is focused on developing non-opioid therapies for pain management. The company is based in San Francisco,CA and was founded in 2014.Explore more
Concentric Analgesics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Concentric Analgesics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Concentric Analgesics had a recent Job posting/layoffs
Check out if Concentric Analgesics is spiking on competitors!
Product Launch: Get notified when Concentric Analgesics launches new products
Congratulate Masked Content for being promoted to Masked Content at Concentric Analgesics
Concentric Analgesics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Concentric Analgesics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Concentric Analgesics recently announced quarterly report
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Concentric Analgesics has new funding data
Recommended Actions
Reach out to Masked Content who joined Concentric Analgesics as Masked Content
Find 2 more new buyers
Compare Similar Companies to Concentric Analgesics
Compare insights from companies similar to Concentric Analgesics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Concentric Analgesics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Concentric Analgesics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Concentric Analgesics.
Concentric Analgesics financials insights
Gather financial insights about Concentric Analgesics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Series A
$6M
2017
Debt
$5.4M
2019
Series B
$77.1M
2020
Debt
$350K
2022
Debt
$20M
Concentric Analgesics Tech Stack
A closer look at the technologies used by Concentric Analgesics
Most Recent Scoops
Open Position
Open Position
Funding
Funding
Concentric Analgesics Inc has received an SBA PPP loan for $350,000-1 million from Live Oak Banking Company.
Funding
Funding
Concentric Analgesics News & Media
Concentric Analgesics Announces Peer-Reviewed Publication of Positive Phase 2 Clinical Data in ANESTHESIOLOGY
SAN FRANCISCO--(BUSINESS WIRE)--Concentric Analgesics, Inc., a clinical-stage biopharmaceutical company developing novel, non-opioid pain therapeutics, today announced publication of a multicenter, randomized clinical trial evaluating vocacapsaicin on the cover of the August 2024 issue of ANESTHESIOLOGY, the highest impact journal in the specialty. Results showed that a single dose of vocacapsaicin significantly reduced pain and opioid use for at least one week after bunionectomy, the most commConcentric Analgesics Announces Positive Results from Pilot Phase 2 Clinical Trial of Vocacapsaicin in Open Laparotomy for Repair of Abdominal Ventral Hernia
SAN FRANCISCO--(BUSINESS WIRE)--Concentric Analgesics, Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing novel, non-opioid pain therapeutics, today announced positive results from its recently completed pilot Phase 2 clinical trial of vocacapsaicin in patients undergoing open laparotomy for ventral hernia repair. Vocacapsaicin is a first-in-class, non-opioid, long-lasting therapeutic with FDA Breakthrough Therapy Designation that is administered as a sinConcentric Analgesics Forges Important Phase 3 Clinical Relationships for Vocacapsaicin, a Non-Opioid Pain Therapy Targeting TRPV1 Receptor
SAN FRANCISCO--(BUSINESS WIRE)--Concentric Analgesics, Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing novel, non-opioid pain therapeutics, today announced two important Phase 3 clinical relationships for its lead product candidate, vocacapsaicin. First, the company has entered into a formal agreement with Evolution Research Group (ERG), a leading postsurgical pain clinical research site network in the U.S., to conduct its registration trials. “FollowiConcentric Analgesics Announces Completion of $20 Million Financing and Appoints Two New Board Members as it Prepares to Initiate Registration-Enabling Phase 3 Studies for Vocacapsaicin
SAN FRANCISCO--(BUSINESS WIRE)--Concentric Analgesics, Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing novel, non-opioid pain therapeutics, today announced the closing of a $20 million convertible note financing from a combination of new and existing investors. In addition, the company announced the appointments of Paul R. Carter and Jonathan R. Lynch to its board of directors. “We are pleased to announce the closing of this oversubscribed financing, w
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Concentric Analgesics
Sign Up For FreeTo access detailed company insights
Concentric Analgesics is a biotechnology company that is focused on developing non-opioid therapies for pain management. The company is based in San Francisco,CA and was founded in 2014.... Read More
